Cassava Sciences stock craters after Alzheimer’s drug trial flops in critical phase
Cassava Sciences, Inc., a clinical-stage biotechnology company, revealed a significant setback in its pursuit of an effective treatment for Alzheimer’s disease. The company reported that ... Read More
Cassava Sciences fined $40m over misleading Alzheimer’s drug trial results
In a sensational revelation, Cassava Sciences, Inc., a biotechnology company that has been the center of attention for its experimental Alzheimer's drug, is now embroiled ... Read More